Limits in virus filtration capability? Impact of virus quality and spike level on virus removal with xenotropic murine leukemia virus

病毒 病毒学 过滤(数学) 生物 化学 数学 统计
作者
David J. Roush,Adam Myrold,Michael S. Burnham,Joseph V. and,Joseph V. Hughes
出处
期刊:Biotechnology Progress [American Chemical Society]
卷期号:31 (1): 135-144 被引量:11
标识
DOI:10.1002/btpr.2020
摘要

Virus filtration (VF) is a key step in an overall viral clearance process since it has been demonstrated to effectively clear a wide range of mammalian viruses with a log reduction value (LRV) > 4. The potential to achieve higher LRV from virus retentive filters has historically been examined using bacteriophage surrogates, which commonly demonstrated a potential of > 9 LRV when using high titer spikes (e.g. 1010 PFU/mL). However, as the filter loading increases, one typically experiences significant decreases in performance and LRV. The 9 LRV value is markedly higher than the current expected range of 4-5 LRV when utilizing mammalian retroviruses on virus removal filters (Miesegaes et al., Dev Biol (Basel) 2010;133:3-101). Recent values have been reported in the literature (Stuckey et al., Biotech Progr 2014;30:79-85) of LRV in excess of 6 for PPV and XMuLV although this result appears to be atypical. LRV for VF with therapeutic proteins could be limited by several factors including process limits (flux decay, load matrix), virus spike level and the analytical methods used for virus detection (i.e. the Limits of Quantitation), as well as the virus spike quality. Research was conducted using the Xenotropic-Murine Leukemia Virus (XMuLV) for its direct relevance to the most commonly cited document, the International Conference of Harmonization (ICH) Q5A (International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use, Geneva, Switzerland, 1999) for viral safety evaluations. A unique aspect of this work is the independent evaluation of the impact of retrovirus quality and virus spike level on VF performance and LRV. The VF studies used XMuLV preparations purified by either ultracentrifugation (Ultra 1) or by chromatographic processes that yielded a more highly purified virus stock (Ultra 2). Two monoclonal antibodies (Mabs) with markedly different filtration characteristics and with similar levels of aggregate (<1.5%) were evaluated with the Ultra 1 and Ultra 2 virus preparations utilizing the Planova 20 N, a small virus removal filter. Impurities in the virus preparation ultimately limited filter loading as measured by determining the volumetric loading condition where 75% flux decay is observed versus initial conditions (V75). This observation occurred with both Mabs with the difference in virus purity more pronounced when very high spike levels were used (>5 vol/vol %). Significant differences were seen for the process performance over a number of lots of the less-pure Ultra 1 virus preparations. Experiments utilizing a developmental lot of the chromatographic purified XMuLV (Ultra 2 Development lot) that had elevated levels of host cell residuals (vs. the final Ultra 2 preparations) suggest that these contaminant residuals can impact virus filter fouling, even if the virus prep is essentially monodisperse. Process studies utilizing an Ultra 2 virus with substantially less host cell residuals and highly monodispersed virus particles demonstrated superior performance and an LRV in excess of 7.7 log10. A model was constructed demonstrating the linear dependence of filtration flux versus filter loading which can be used to predict the V75 for a range of virus spike levels conditions using this highly purified virus. Fine tuning the virus spike level with this model can ultimately maximize the LRV for the virus filter step, essentially adding the LRV equivalent of another process step (i.e. protein A or CEX chromatography). © 2014 American Institute of Chemical Engineers Biotechnol. Prog., 31:135–144, 2015

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
开朗豪英完成签到 ,获得积分10
1秒前
蓝景轩辕完成签到 ,获得积分10
2秒前
2秒前
hiraabb完成签到 ,获得积分10
5秒前
ymxlcfc完成签到 ,获得积分0
8秒前
firewood完成签到,获得积分10
13秒前
PHI完成签到 ,获得积分10
15秒前
美丽凛完成签到 ,获得积分10
16秒前
18秒前
笑观天下完成签到,获得积分10
23秒前
cdercder应助科研通管家采纳,获得10
24秒前
cdercder应助科研通管家采纳,获得10
24秒前
科研通AI2S应助科研通管家采纳,获得10
24秒前
cdercder应助科研通管家采纳,获得10
24秒前
lulu发布了新的文献求助20
27秒前
Hello应助dracovu采纳,获得10
28秒前
Reader完成签到 ,获得积分10
29秒前
Jerry完成签到,获得积分10
29秒前
STEMOS完成签到 ,获得积分10
30秒前
zhang568完成签到 ,获得积分10
39秒前
gincle完成签到,获得积分10
39秒前
46秒前
群青完成签到 ,获得积分10
47秒前
55秒前
蓝色完成签到,获得积分10
56秒前
57秒前
在下小李发布了新的文献求助10
1分钟前
1分钟前
卢西完成签到,获得积分10
1分钟前
dracovu发布了新的文献求助10
1分钟前
健康乐悠悠完成签到 ,获得积分10
1分钟前
Tiantian完成签到 ,获得积分10
1分钟前
Lucas应助otto12306采纳,获得10
1分钟前
1分钟前
开心的盼波完成签到 ,获得积分10
1分钟前
1分钟前
cepha完成签到 ,获得积分10
1分钟前
忧虑的靖巧完成签到 ,获得积分0
1分钟前
在下小李发布了新的文献求助10
1分钟前
木卫二完成签到 ,获得积分10
1分钟前
高分求助中
Clinical Epidemiology: The Essentials, 6e 10000
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
The Graphene Handbook (2019 Edition) 800
Adhesion Science: Principles & Practice 800
Signals, Systems, and Signal Processing 610
Fundamentals of Pharmaceutical and Biologics Regulations: A Global Perspective, Second Edition 600
久松真一著作集〈第5巻〉禅と芸術 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 物理 内科学 复合材料 催化作用 物理化学 光电子学 电极 细胞生物学 基因 无机化学
热门帖子
关注 科研通微信公众号,转发送积分 6554154
求助须知:如何正确求助?哪些是违规求助? 8339033
关于积分的说明 17864821
捐赠科研通 5670703
什么是DOI,文献DOI怎么找? 2939899
邀请新用户注册赠送积分活动 1915770
关于科研通互助平台的介绍 1785125